DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/xcftdl/global_pancreatic) has announced the addition of the "Global Pancreatic Cancer Pipeline Highlights - 2014" report to their offering.
The latest report Pancreatic Cancer Pipeline Highlights - 2014, provides most up-to-date information on key pipeline molecules in the global pancreatic cancer market. It covers emerging therapies for pancreatic cancer in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.
Clinical Trial Stages:
The report provides pancreatic cancer pipeline molecules by clinical trial stages including both early and late stage development - phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.
Drug Mechanism Classes:
The report provides pancreatic cancer pipeline molecules by their dominant mechanism of action. This helps executives categorize molecules based on their drug class and also assess the strengths and weaknesses of compounds.
Company:
The report provides pancreatic cancer pipeline molecules by the Originator Company.
Short-term Launch Highlights:
Find out which pancreatic cancer pipeline products will be launched in the US and Ex-US till 2017.
Summary:
- Pancreatic Cancer phase 3 clinical trial pipeline molecules
- Pancreatic Cancer phase 2 clinical trial pipeline molecules
- Pancreatic Cancer phase 1 clinical trial pipeline molecules
- Pancreatic Cancer preclinical research pipeline molecules
- Pancreatic Cancer discovery stage pipeline molecules
- Pancreatic Cancer pipeline molecules short-term launch highlights
Key Topics Covered:
1. Pancreatic Cancer Pipeline by Stages
2. Pancreatic Cancer Pipeline by Drug Class
3. Pancreatic Cancer Pipeline by Company
4. Pancreatic Cancer Phase 3 Clinical Trial Insights
5. Pancreatic Cancer Phase 2 Clinical Trial Insights
6. Pancreatic Cancer Phase 1 Clinical Trial Insights
7. Pancreatic Cancer Preclinical Research Insights
8. Pancreatic Cancer Discovery Stage Insights
9. Appendix
10. Research Methodology
Table
Figure
For more information visit http://www.researchandmarkets.com/research/xcftdl/global_pancreatic
About Research and Markets
Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
